• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳铁蛋白的体外抗菌活性、其与头孢泊肟酯的联合使用及头孢泊肟酯的临床疗效

In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil.

作者信息

Chimura T, Hirayama T, Nakahara M

机构信息

Department of Obstetrics and Gynecology, School of Medicine, Yamagata University.

出版信息

Jpn J Antibiot. 1993 Jun;46(6):482-5.

PMID:8360983
Abstract

As one of the biodefense mechanisms, lactoferrin (LFN) in the secreta of female genital organ may be an interesting biological material in view of its antimicrobial activity. In the present study, we investigated antimicrobial activities of LFN and its combination with cefpodoxime proxetil (CPDX-PR), we also as evaluated clinical effect of CPDX-PR. The following results were obtained. 1. Antimicrobial activities of LFN were tested against 15 strains of 10 species of bacteria, and potent activities against Staphylococcus aureus 209P, Escherichia coli, Klebsiella pneumoniae and Proteus spp. were found. 2. In a concomitant use of LFN with CPDX-PR (a checkerboard method), synergistic actions were observed against S. aureus 209P, E. coli STf, K. pneumoniae 602 and Pseudomonas aeruginosa 1046, and additive actions against E. coli NIHJ and Providencia rettgeri 1603. In 3 strains, the MICs of CPDX-PR in the presence of LFN were reduced to < 1/64. 3. In the evaluation of clinical effect of CPDX-PR, efficacy rates were 53/57 (92.9%) in a patient group with infections. The incidence of adverse reaction was 0/57.

摘要

作为生物防御机制之一,女性生殖器官分泌物中的乳铁蛋白(LFN)因其抗菌活性可能是一种有趣的生物材料。在本研究中,我们研究了LFN及其与头孢泊肟酯(CPDX-PR)联合使用的抗菌活性,还评估了CPDX-PR的临床效果。获得了以下结果。1. 测试了LFN对10种细菌的15个菌株的抗菌活性,发现其对金黄色葡萄球菌209P、大肠杆菌、肺炎克雷伯菌和变形杆菌属有较强活性。2. 在LFN与CPDX-PR联合使用时(棋盘法),观察到对金黄色葡萄球菌209P、大肠杆菌STf、肺炎克雷伯菌602和铜绿假单胞菌1046有协同作用,对大肠杆菌NIHJ和雷氏普罗威登斯菌1603有相加作用。在3个菌株中,LFN存在时CPDX-PR的最低抑菌浓度降至<1/64。3. 在评估CPDX-PR的临床效果时,感染患者组的有效率为53/57(92.9%)。不良反应发生率为0/57。

相似文献

1
In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil.乳铁蛋白的体外抗菌活性、其与头孢泊肟酯的联合使用及头孢泊肟酯的临床疗效
Jpn J Antibiot. 1993 Jun;46(6):482-5.
2
[Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].头孢泊肟酯在儿科领域的细菌学、药代动力学及临床研究
Jpn J Antibiot. 1989 Jul;42(7):1519-46.
3
[Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].头孢泊肟酯在儿科领域的细菌学、药代动力学及临床研究
Jpn J Antibiot. 1989 Jul;42(7):1593-606.
4
[Pharmacokinetic and clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].头孢泊肟酯干糖浆在儿科领域的药代动力学及临床研究
Jpn J Antibiot. 1989 Jul;42(7):1629-66.
5
[Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].
Jpn J Antibiot. 1989 Jul;42(7):1547-60.
6
[Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].[2000年和2001年头孢泊肟对临床分离株的抗菌活性]
Jpn J Antibiot. 2002 Dec;55(6):827-43.
7
[Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
Jpn J Antibiot. 1994 Jan;47(1):84-92.
8
[Evaluation of cefpodoxime proxetil in the pediatric field].[头孢泊肟酯在儿科领域的评估]
Jpn J Antibiot. 1989 Jul;42(7):1505-18.
9
[Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].头孢泊肟酯治疗皮肤及软组织感染的临床评价。头孢泊肟酯与头孢克洛的双盲比较
Jpn J Antibiot. 1988 Oct;41(10):1517-37.
10
[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].头孢泊肟酯对青霉素耐药肺炎链球菌的体外和体内活性
Jpn J Antibiot. 1999 Aug;52(8):533-40.

引用本文的文献

1
Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trial.乳铁蛋白预防重症患者医院感染(PREVAIL研究):一项随机对照试验的研究方案
Trials. 2016 Sep 29;17(1):474. doi: 10.1186/s13063-016-1590-z.
2
In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins.人乳蛋白对痢疾志贺氏菌、福氏志贺氏菌和宋内志贺氏菌临床菌株的体外黏附和侵袭抑制作用
BMC Microbiol. 2004 Apr 28;4:18. doi: 10.1186/1471-2180-4-18.